What is the official website of Fosun Pharma ?

The official website of Fosun Pharma is http://www.fosunpharma.com/.

What is Fosun Pharma's cybersecurity risk score?

Fosun Pharma has an AI-generated cybersecurity risk score of 764 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Fosun Pharma experienced?

According to Rankiteo, Fosun Pharma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Fosun Pharma been affected by any supply chain cyber incidents ?

According to Rankiteo, Fosun Pharma has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Fosun Pharma have SOC 2 Type 1 certification ?

According to Rankiteo, Fosun Pharma is not certified under SOC 2 Type 1.

Does Fosun Pharma have SOC 2 Type 2 certification ?

According to Rankiteo, Fosun Pharma does not hold a SOC 2 Type 2 certification.

Does Fosun Pharma comply with GDPR ?

According to Rankiteo, Fosun Pharma is not listed as GDPR compliant.

Does Fosun Pharma have PCI DSS certification ?

According to Rankiteo, Fosun Pharma does not currently maintain PCI DSS compliance.

Does Fosun Pharma comply with HIPAA ?

According to Rankiteo, Fosun Pharma is not compliant with HIPAA regulations.

Does Fosun Pharma have ISO 27001 certification ?

According to Rankiteo,Fosun Pharma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Fosun Pharma operate in ?

Fosun Pharma operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Fosun Pharma have ?

Fosun Pharma employs approximately 5,087 people worldwide.

Does Fosun Pharma own any subsidiaries ?

Fosun Pharma presently has no subsidiaries across any sectors.

How many LinkedIn followers does Fosun Pharma have ?

Fosun Pharma's official LinkedIn profile has approximately 26,633 followers.

What is the NAICS classification code for Fosun Pharma ?

Fosun Pharma is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Fosun Pharma have a Crunchbase profile ?

Yes, Fosun Pharma has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/fosun-pharmaceutical.

Does Fosun Pharma have a LinkedIn profile ?

Yes, Fosun Pharma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/fosunpharma.

How many cybersecurity incidents has Fosun Pharma experienced ?

As of September 18, 2026, Rankiteo reports that Fosun Pharma has not experienced any cybersecurity incidents.

How many peer or competitor companies does Fosun Pharma have ?

Fosun Pharma has an estimated 5,766 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Fosun Pharma

Boost Score +25 with badge (5 left)

764

/1000

Fair

789

/1000

Fair

Fosun Pharma Vendor Cyber Rating & Cyber Score

fosunpharma.com

cb in

Add Your Compliance Badge

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; SSE: 600196, HKEX: 02196) is a leading innovation-driven global healthcare company operating in the fields of pharmaceuticals, medical devices & diagnostics, and healthcare services. Through its strategic alliance with Sinopharm Group Co., Ltd., Fosun Pharma further extends its capabilities in pharmaceutical commerce. Over the past 30 years since its establishment, Fosun Pharma has maintained deep roots in China while strategically expanding its global presence. The company has been actively implementing its “4IN” strategy -Innovation, Internationalization, Intelligentization, and Integration, with core business operations now spanning major overseas markets

Fosun Pharma

Fosun Pharma CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Fosun Pharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Fosun Pharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fosun Pharma in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Fosun Pharma in 2026.

Incident Types Fosun Pharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fosun Pharma in 2026.

Incident History - Fosun Pharma (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Fosun Pharma Subsidiaries

Fosun Pharma

Pharmaceutical Manufacturing

Website: http://www.fosunpharma.com/

Company Size: 5,087

Gland Pharma LimitedPharmaceutical Manufacturing

Fosun 复星Consumer Services

Club MedHospitality

Club Med PropertyImmobilier

Meetings & Events by Club MedEvents Services

Club Med Meetings & Events (AU & NZ)Events Services

Millennium bcpBanking

Rio Bravo InvestimentosInvestment Management

Peak ReInsurance

The Bund Finance CenterLeasing Non-residential Real Estate

Alma LasersMedical Equipment Manufacturing

FemiLiftMedical Equipment Manufacturing

BeautiFill made by LipoLifeMedical Device

Alma Lasers North AmericaMedical Equipment Manufacturing

Alma Lasers GmbHMedical Device

FF OpsCoRetail Luxury Goods and Jewelry

复星保德信人寿保险有限公司Insurance

Fosun HiveReal Estate

Breas MedicalMedical Equipment Manufacturing

ERS Congress 2019Medical Device

HenliusBiotechnology Research

Henlius USA Inc.Biotechnology Research

Guilin Pharmaceutical Co., Ltd.Pharmaceutical Manufacturing

Loading…

Fosun Pharma Similar Companies

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Fresenius Kabi

fresenius-kabi.com

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Medical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Loading…

NEWS

Fosun Pharma CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

September 26, 2025 07:00 AM

Trump's New 100% Tariff On Patented Drugs Triggers Slide In Asian Pharma Stocks

Trump said the tariffs will go into effect on October 1, but the levy won't apply to companies that have started building manufacturing...

Read Article

June 06, 2022 07:00 AM

China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers

Fosun Pharmaceutical, the pharmaceutical arm of investment firm Fosun International controlled by China billionaire Guo Guangchang, will pay up to S$217.6...

Read Article

October 22, 2020 07:00 AM

Dr. Reddy's shuts 'key' plants worldwide after potential cyberattack hits COVID work

Dr. Reddy's Laboratories isolated all data center services as a preventive measure after detecting a breach, the company said Thursday.

Read Article

March 17, 2017 07:00 AM

PBM Sells Interest in Breas Medical to Shanghai Fosun Pharmaceutical

PBM Capital Group said it sold a majority interest in Breas Medical Group to Shanghai Fosun Pharmaceutical (Group) Co., a publicly traded...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-93436

SUMMARY

vLLM through 0.29.0 fails to properly clean up decode-side metadata for rejected inference requests in prefill/decode disaggregated deployments. Remote attackers can submit requests with max_tokens=0 to exhaust decode-worker memory without bound until the worker restarts.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-93435

SUMMARY

redis-parser through 3.0.0 contains a denial of service vulnerability in the RESP protocol parser that allows malicious Redis endpoints to crash the client process through unbounded recursion on nested arrays. Attackers can send crafted RESP byte streams with repeated array headers that exhaust the V8 call stack, causing an uncaught RangeError that terminates the Node.js process without triggering error handling callbacks.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-87701

SUMMARY

Improper neutralization of special elements in output used by a downstream component ('injection') in Azure Cosmos DB allows an authorized attacker to elevate privileges over a network.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 9.6)

cvss3

Base Score: 9.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:N

Impact Score

5.8

Exploitability

3.1

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-87701

CVE-2026-85917

SUMMARY

Server-side request forgery (ssrf) in Azure AI Foundry allows an unauthorized attacker to elevate privileges over a network.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-85917

CVE-2026-85889

SUMMARY

Missing authentication for critical function in Azure AI Foundry allows an unauthorized attacker to elevate privileges over a network.

Published

Date2026-09-17

Updated

Date2026-09-17

RISK INFORMATION (Score: 10)

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

Impact Score

Exploitability

3.9

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-85889

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Fosun Pharma Vendor Cyber Rating & Cyber Score

Fosun Pharma A.I CyberSecurity Scoring

Fosun Pharma CyberSecurity News & History

Fosun Pharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Fosun Pharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Fosun Pharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Fosun Pharma (X = Date, Y = Severity)

Fosun Pharma Subsidiaries

Fosun Pharma

Fosun Pharma Similar Companies

Alkem Laboratories Ltd.

Alembic Pharmaceuticals Limited

Sanofi

Servier

Fresenius Kabi

Ipca Laboratories Limited

Sandoz

PT Kalbe Farma, Tbk

UCB

Fosun Pharma CyberSecurity News

Trump's New 100% Tariff On Patented Drugs Triggers Slide In Asian Pharma Stocks

China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers

Dr. Reddy's shuts 'key' plants worldwide after potential cyberattack hits COVID work

PBM Sells Interest in Breas Medical to Shanghai Fosun Pharmaceutical

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Fosun Pharma CyberSecurity News & History

Fosun Pharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Fosun Pharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Fosun Pharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Fosun Pharma (X = Date, Y = Severity)

Fosun Pharma Subsidiaries

Fosun Pharma

Fosun Pharma Similar Companies

Alkem Laboratories Ltd.

Alembic Pharmaceuticals Limited

Sanofi

Servier

Fresenius Kabi

Ipca Laboratories Limited

Sandoz

PT Kalbe Farma, Tbk

UCB

Fosun Pharma CyberSecurity News

Trump's New 100% Tariff On Patented Drugs Triggers Slide In Asian Pharma Stocks

China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers

Dr. Reddy's shuts 'key' plants worldwide after potential cyberattack hits COVID work

PBM Sells Interest in Breas Medical to Shanghai Fosun Pharmaceutical

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo